Annual FCF
-$6.47 M
-$650.30 K-11.17%
30 June 2024
Summary:
NanoViricides annual free cash flow is currently -$6.47 million, with the most recent change of -$650.30 thousand (-11.17%) on 30 June 2024. During the last 3 years, it has risen by +$1.98 million (+23.43%).NNVC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.64 M
-$1.06 M-67.24%
01 September 2024
Summary:
NanoViricides quarterly free cash flow is currently -$2.64 million, with the most recent change of -$1.06 million (-67.24%) on 01 September 2024. Over the past year, it has dropped by -$917.20 thousand (-53.19%). NNVC quarterly FCF is now -739.94% below its all-time high of -$314.50 thousand, reached on 30 June 2007.NNVC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$7.93 M
-$1.46 M-22.58%
01 September 2024
Summary:
NanoViricides TTM free cash flow is currently -$7.93 million, with the most recent change of -$1.46 million (-22.58%) on 01 September 2024. Over the past year, it has dropped by -$1.73 million (-27.90%). NNVC TTM FCF is now -917.65% below its all-time high of -$779.60 thousand, reached on 30 September 2006.NNVC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NNVC Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.2% | -53.2% | -27.9% |
| 3 y3 years | +23.4% | -14.9% | -14.9% |
| 5 y5 years | +5.9% | -134.6% | -26.7% |
NNVC Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.2% | +23.4% | -145.2% | at low | -39.4% | at low |
| 5 y | 5 years | -11.2% | +23.4% | -252.9% | at low | -39.4% | +8.9% |
| alltime | all time | <-9999.0% | +50.1% | -739.9% | +55.4% | -917.6% | +42.8% |
NanoViricides Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.64 M(+67.2%) | -$7.93 M(+22.6%) |
| June 2024 | -$6.47 M(+11.2%) | -$1.58 M(-20.6%) | -$6.47 M(+1.2%) |
| Mar 2024 | - | -$1.99 M(+15.3%) | -$6.39 M(+3.1%) |
| Dec 2023 | - | -$1.72 M(+46.1%) | -$6.20 M(+4.7%) |
| Sept 2023 | - | -$1.18 M(-21.4%) | -$5.92 M(+1.8%) |
| June 2023 | -$5.82 M(-6.3%) | -$1.50 M(-16.5%) | -$5.82 M(+0.5%) |
| Mar 2023 | - | -$1.80 M(+24.3%) | -$5.79 M(+1.8%) |
| Dec 2022 | - | -$1.45 M(+34.2%) | -$5.69 M(-13.0%) |
| Sept 2022 | - | -$1.08 M(-26.9%) | -$6.54 M(+5.3%) |
| June 2022 | -$6.22 M(-26.5%) | -$1.47 M(-13.1%) | -$6.22 M(-11.9%) |
| Mar 2022 | - | -$1.69 M(-26.3%) | -$7.05 M(+2.2%) |
| Dec 2021 | - | -$2.30 M(+207.2%) | -$6.91 M(-0.4%) |
| Sept 2021 | - | -$748.50 K(-67.6%) | -$6.93 M(-18.0%) |
| June 2021 | -$8.45 M(+26.6%) | -$2.31 M(+49.6%) | -$8.45 M(+7.6%) |
| Mar 2021 | - | -$1.55 M(-33.5%) | -$7.85 M(-9.8%) |
| Dec 2020 | - | -$2.32 M(+2.3%) | -$8.70 M(+16.0%) |
| Sept 2020 | - | -$2.27 M(+32.6%) | -$7.51 M(+12.5%) |
| June 2020 | -$6.67 M(-2.9%) | -$1.71 M(-28.5%) | -$6.67 M(+0.5%) |
| Mar 2020 | - | -$2.40 M(+112.8%) | -$6.64 M(+6.1%) |
| Dec 2019 | - | -$1.13 M(-21.7%) | -$6.26 M(-14.4%) |
| Sept 2019 | - | -$1.44 M(-14.5%) | -$7.32 M(+6.4%) |
| June 2019 | -$6.88 M(-14.2%) | -$1.68 M(-16.6%) | -$6.88 M(-21.2%) |
| Mar 2019 | - | -$2.02 M(-7.4%) | -$8.73 M(+7.2%) |
| Dec 2018 | - | -$2.18 M(+118.0%) | -$8.14 M(+9.6%) |
| Sept 2018 | - | -$999.40 K(-71.7%) | -$7.43 M(-7.3%) |
| June 2018 | -$8.02 M(-0.6%) | -$3.54 M(+147.5%) | -$8.02 M(+44.8%) |
| Mar 2018 | - | -$1.43 M(-2.5%) | -$5.54 M(-11.5%) |
| Dec 2017 | - | -$1.47 M(-7.6%) | -$6.26 M(-15.5%) |
| Sept 2017 | - | -$1.59 M(+50.4%) | -$7.40 M(-8.2%) |
| June 2017 | -$8.06 M(+10.4%) | -$1.06 M(-50.8%) | -$8.06 M(-4.5%) |
| Mar 2017 | - | -$2.15 M(-17.8%) | -$8.44 M(-5.5%) |
| Dec 2016 | - | -$2.61 M(+16.1%) | -$8.94 M(+18.1%) |
| Sept 2016 | - | -$2.25 M(+56.8%) | -$7.57 M(+3.6%) |
| June 2016 | -$7.31 M(-43.7%) | -$1.43 M(-45.7%) | -$7.31 M(-12.2%) |
| Mar 2016 | - | -$2.64 M(+112.6%) | -$8.32 M(+3.8%) |
| Dec 2015 | - | -$1.24 M(-37.5%) | -$8.02 M(-36.8%) |
| Sept 2015 | - | -$1.99 M(-18.9%) | -$12.70 M(-2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | -$12.97 M(+12.2%) | -$2.45 M(+4.8%) | -$12.97 M(-0.9%) |
| Mar 2015 | - | -$2.34 M(-60.5%) | -$13.09 M(-5.6%) |
| Dec 2014 | - | -$5.92 M(+162.3%) | -$13.87 M(+35.7%) |
| Sept 2014 | - | -$2.26 M(-12.1%) | -$10.22 M(-11.6%) |
| June 2014 | -$11.56 M(+97.3%) | -$2.57 M(-17.7%) | -$11.56 M(+11.5%) |
| Mar 2014 | - | -$3.12 M(+37.1%) | -$10.37 M(+15.8%) |
| Dec 2013 | - | -$2.28 M(-36.7%) | -$8.96 M(+11.2%) |
| Sept 2013 | - | -$3.60 M(+162.3%) | -$8.05 M(+38.9%) |
| June 2013 | -$5.86 M(+37.1%) | -$1.37 M(-19.7%) | -$5.80 M(+8.9%) |
| Mar 2013 | - | -$1.71 M(+24.5%) | -$5.32 M(+5.5%) |
| Dec 2012 | - | -$1.37 M(+2.0%) | -$5.04 M(+2.6%) |
| Sept 2012 | - | -$1.35 M(+50.0%) | -$4.92 M(+15.0%) |
| June 2012 | -$4.28 M(-9.0%) | -$896.60 K(-37.3%) | -$4.28 M(+0.8%) |
| Mar 2012 | - | -$1.43 M(+14.9%) | -$4.24 M(+4.1%) |
| Dec 2011 | - | -$1.24 M(+76.4%) | -$4.08 M(+6.4%) |
| Sept 2011 | - | -$705.40 K(-18.4%) | -$3.83 M(-18.5%) |
| June 2011 | -$4.70 M(+68.4%) | -$864.40 K(-31.7%) | -$4.70 M(+2.8%) |
| Mar 2011 | - | -$1.26 M(+26.5%) | -$4.57 M(+4.7%) |
| Dec 2010 | - | -$999.50 K(-36.5%) | -$4.37 M(+18.4%) |
| Sept 2010 | - | -$1.57 M(+113.4%) | -$3.69 M(+32.2%) |
| June 2010 | -$2.79 M(-18.7%) | -$737.20 K(-30.4%) | -$2.79 M(+10.6%) |
| Mar 2010 | - | -$1.06 M(+229.6%) | -$2.52 M(+9.8%) |
| Dec 2009 | - | -$321.50 K(-52.3%) | -$2.30 M(-24.4%) |
| Sept 2009 | - | -$673.90 K(+43.7%) | -$3.04 M(-11.6%) |
| June 2009 | -$3.43 M(+28.6%) | -$469.00 K(-43.7%) | -$3.43 M(+2.0%) |
| Mar 2009 | - | -$833.70 K(-21.5%) | -$3.37 M(+3.2%) |
| Dec 2008 | - | -$1.06 M(-0.9%) | -$3.26 M(+4.0%) |
| Sept 2008 | - | -$1.07 M(+165.8%) | -$3.14 M(+17.5%) |
| June 2008 | -$2.67 M(+13.2%) | -$402.80 K(-44.8%) | -$2.67 M(+3.4%) |
| Mar 2008 | - | -$729.40 K(-22.0%) | -$2.58 M(-4.0%) |
| Dec 2007 | - | -$935.00 K(+54.7%) | -$2.69 M(+23.2%) |
| Sept 2007 | - | -$604.30 K(+92.1%) | -$2.18 M(-7.4%) |
| June 2007 | -$2.36 M(+29.2%) | -$314.50 K(-62.4%) | -$2.36 M(+15.4%) |
| Mar 2007 | - | -$836.00 K(+94.8%) | -$2.04 M(+69.2%) |
| Dec 2006 | - | -$429.10 K(-45.0%) | -$1.21 M(+55.0%) |
| Sept 2006 | - | -$779.60 K | -$779.60 K |
| June 2006 | -$1.83 M(<-9900.0%) | - | - |
| June 2005 | $0.00 | - | - |
FAQ
- What is NanoViricides annual free cash flow?
- What is the all time high annual FCF for NanoViricides?
- What is NanoViricides annual FCF year-on-year change?
- What is NanoViricides quarterly free cash flow?
- What is the all time high quarterly FCF for NanoViricides?
- What is NanoViricides quarterly FCF year-on-year change?
- What is NanoViricides TTM free cash flow?
- What is the all time high TTM FCF for NanoViricides?
- What is NanoViricides TTM FCF year-on-year change?
What is NanoViricides annual free cash flow?
The current annual FCF of NNVC is -$6.47 M
What is the all time high annual FCF for NanoViricides?
NanoViricides all-time high annual free cash flow is $0.00
What is NanoViricides annual FCF year-on-year change?
Over the past year, NNVC annual free cash flow has changed by -$650.30 K (-11.17%)
What is NanoViricides quarterly free cash flow?
The current quarterly FCF of NNVC is -$2.64 M
What is the all time high quarterly FCF for NanoViricides?
NanoViricides all-time high quarterly free cash flow is -$314.50 K
What is NanoViricides quarterly FCF year-on-year change?
Over the past year, NNVC quarterly free cash flow has changed by -$917.20 K (-53.19%)
What is NanoViricides TTM free cash flow?
The current TTM FCF of NNVC is -$7.93 M
What is the all time high TTM FCF for NanoViricides?
NanoViricides all-time high TTM free cash flow is -$779.60 K
What is NanoViricides TTM FCF year-on-year change?
Over the past year, NNVC TTM free cash flow has changed by -$1.73 M (-27.90%)